0.783
price up icon7.26%   0.053
after-market Handel nachbörslich: .78 -0.003 -0.38%
loading
Schlusskurs vom Vortag:
$0.73
Offen:
$0.7311
24-Stunden-Volumen:
132.00K
Relative Volume:
0.69
Marktkapitalisierung:
$91.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-1.3982
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
-1.31%
1M Leistung:
+7.00%
6M Leistung:
-53.67%
1J Leistung:
-65.51%
1-Tages-Spanne:
Value
$0.73
$0.7926
1-Wochen-Bereich:
Value
$0.6937
$0.8476
52-Wochen-Spanne:
Value
$0.66
$3.09

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Firmenname
Nautilus Biotechnology Inc
Name
Telefon
206-333-2001
Name
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Name
Mitarbeiter
134
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
NAUT's Discussions on Twitter

Vergleichen Sie NAUT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NAUT
Nautilus Biotechnology Inc
0.783 91.46M 0 -70.78M -61.27M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-05 Herabstufung Goldman Neutral → Sell
2024-06-27 Eingeleitet Guggenheim Buy
2024-06-03 Fortgesetzt Jefferies Hold
2022-01-06 Eingeleitet Morgan Stanley Equal-Weight
2021-11-02 Eingeleitet Cowen Outperform
2021-08-04 Eingeleitet Goldman Neutral
2021-07-13 Eingeleitet Jefferies Buy
Alle ansehen

Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten

pulisher
Jun 14, 2025

Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Home Product Center Public (OTCMKTS:HPCRF) Trading Up 20.5% – Should You Buy? - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Bought by Jane Street Group LLC - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Raises Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer - Business Wire

Jun 02, 2025
pulisher
May 30, 2025

Northern Trust Corp Sells 32,695 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 30, 2025
pulisher
May 27, 2025

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

May 27, 2025
pulisher
May 20, 2025

20,256 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Cubist Systematic Strategies LLC - Defense World

May 20, 2025
pulisher
May 16, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 16, 2025
pulisher
May 15, 2025

Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insiders continue to buy Nautilus Biotechnology, Inc. (NASDAQ:NAUT) and now own 31% shares - simplywall.st

May 15, 2025
pulisher
May 13, 2025

Nautilus Biotechnology chief scientist buys $9,885 in common stock By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Has $92,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 13, 2025
pulisher
May 13, 2025

Barclays PLC Buys 19,030 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 13, 2025
pulisher
May 12, 2025

Nautilus Biotechnology chief scientist buys $9,885 in common stock - Investing.com

May 12, 2025
pulisher
May 12, 2025

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - Barchart.com

May 12, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Acquires 95,521 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 05, 2025
pulisher
May 04, 2025

JPMorgan Chase & Co. Raises Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 04, 2025
pulisher
May 04, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Update - Defense World

May 04, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology Reports Q1 2025 Financial Results - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology targets late 2026 platform launch amid proteoform assay advancements - MSN

Apr 30, 2025
pulisher
Apr 29, 2025

Nautilus Biotech’s Earnings Call Highlights Progress and Promise - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology Reports First Quarter 2025 Financial Results - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Earnings call transcript: Nautilus Biotechnology Q1 2025 surprises with EPS beat - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology (NAUT) Anticipates Tau Proteoform Assay L - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology Posts Qtrly Loss Per Share $0.13 - marketscreener.com

Apr 29, 2025
pulisher
Apr 27, 2025

Nautilus Biotechnology (NAUT) Expected to Announce Quarterly Earnings on Tuesday - American Banking and Market News

Apr 27, 2025
pulisher
Apr 27, 2025

Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Nautilus Biotechnology Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Increases By 20.5% - Defense World

Apr 23, 2025
pulisher
Apr 17, 2025

Wells Fargo & Company MN Sells 12,607 Shares of Commercial Metals (NYSE:CMC) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - The Manila Times

Apr 16, 2025
pulisher
Apr 05, 2025

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - MarketScreener

Apr 05, 2025
pulisher
Apr 02, 2025

NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Position Decreased by Charles Schwab Investment Management Inc. - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Takes $28,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Yahoo Finance

Mar 31, 2025
pulisher
Mar 12, 2025

Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments - TipRanks

Mar 12, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 03, 2025
pulisher
Mar 01, 2025

Nautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026 - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT) - Seeking Alpha

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating - Investing.com

Feb 28, 2025

Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Mallick Parag
Chief Scientist
May 08 '25
Buy
0.73
12,000
8,788
20,491,892
Mallick Parag
Chief Scientist
May 12 '25
Buy
0.73
1,500
1,098
20,493,392
Patel Sujal M
CEO, President, and Secretary
Mar 19 '25
Buy
0.99
53,300
53,028
10,117,788
Patel Sujal M
CEO, President, and Secretary
Mar 20 '25
Buy
1.00
23,933
23,890
10,141,721
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):